Trace minerals are micronutrients delivered in small quantities, but with significant impacts on poultry health, productivity ...

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2025 Earnings Call Transcript February 11, 2026 Vanda Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-2.39 EPS, expectations were ...

Lilly joins the growing list of big pharma companies hoping to see success from their acquired in vivo CAR-T programmes.

Detailed price information for Immutep Ltd ADR (IMMP-Q) from The Globe and Mail including charting and trades.

Krystal Biotech received FDA RMAT designation for inhaled KB707 in advanced NSCLC, based on a 36% ORR in heavily pretreated ...

A new case report was published in Volume 17 of Oncotarget on February 6, 2026, titled “Exploring the potential link between ...

Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved ...

Citius Oncology, Inc. ("Citius Oncology") , the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") , today announced that it has entered into an exclusive distribution ...

FDA clearance covers pembrolizumab plus paclitaxel ± bevacizumab for PD-L1 CPS ≥1 platinum-resistant disease after one or two prior systemic regimens, introducing PD-1 inhibition into this treatment ...

A new case report was published in Volume 17 of Oncotarget on February 6, 2026, titled "Exploring the potential link between mRNA COVID-19 vaccinations and cancer: A case report with a review of ...

Gyala Therapeutics initiates phase I/IIa trial of a CAR-T cell therapy for acute leukaemias with limited treatment: Barcelona, Spain Wednesday, February 11, 2026, 18:00 Hrs [IST] ...